MANUFACTURERS LIFE INSURANCE COMPANY, THE - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$71,247
-53.7%
20,9550.0%0.00%
Q2 2023$154,019
-25.6%
20,955
+4.9%
0.00%
Q1 2023$206,900
-15.1%
19,971
-3.2%
0.00%
Q4 2022$243,569
-42.2%
20,624
+2.8%
0.00%
Q3 2022$421,143
-33.6%
20,064
-1.9%
0.00%
Q2 2022$634,644
-94.8%
20,446
-93.1%
0.00%
-100.0%
Q1 2022$12,104,283
-75.2%
294,795
-73.4%
0.01%
-73.3%
Q4 2021$48,876,000
-30.3%
1,107,772
-20.9%
0.03%
-47.4%
Q3 2021$70,133,000
-17.7%
1,400,682
+3.6%
0.06%
-17.4%
Q2 2021$85,199,000
-23.5%
1,352,582
+12.8%
0.07%
-28.9%
Q1 2021$111,421,000
+15.0%
1,199,231
+10.9%
0.10%
+9.0%
Q4 2020$96,913,000
+5.0%
1,081,617
+21.1%
0.09%
-6.3%
Q3 2020$92,319,000
+26.3%
893,438
-7.8%
0.10%
+37.7%
Q2 2020$73,092,000
+40.0%
969,012
+7.4%
0.07%
+19.0%
Q1 2020$52,208,000
+57.3%
902,317
+46.7%
0.06%
+65.7%
Q4 2019$33,192,000
+30.9%
615,243
+23.8%
0.04%
+25.0%
Q3 2019$25,363,000
-1.4%
497,114
-6.6%
0.03%
-6.7%
Q2 2019$25,725,000
+7.4%
532,490
+12.3%
0.03%
+15.4%
Q1 2019$23,959,000
+1377.1%
474,247
+1633.3%
0.03%
+1200.0%
Q4 2018$1,622,000
-14.7%
27,361
-5.3%
0.00%0.0%
Q3 2018$1,902,000
+14.0%
28,905
-12.5%
0.00%0.0%
Q2 2018$1,668,000
+24.5%
33,044
+29.8%
0.00%
+100.0%
Q1 2018$1,340,000
-95.8%
25,449
-96.3%
0.00%
-97.1%
Q4 2017$31,811,000
+21.1%
684,537
+5.4%
0.03%
+9.7%
Q3 2017$26,262,000
+22.7%
649,220
+2.8%
0.03%
+19.2%
Q2 2017$21,409,000
+19.7%
631,304
+2.5%
0.03%
+13.0%
Q1 2017$17,888,000
-27.1%
615,990
-17.6%
0.02%
-34.3%
Q4 2016$24,550,000
+19.9%
747,573
+15.1%
0.04%
+16.7%
Q3 2016$20,471,000
+16.7%
649,241
-1.7%
0.03%
+11.1%
Q2 2016$17,545,000
-40.1%
660,656
-20.5%
0.03%
+8.0%
Q1 2016$29,279,000
+16.3%
831,340
+32.1%
0.02%
+4.2%
Q4 2015$25,175,000
+28.4%
629,222
-8.6%
0.02%
+14.3%
Q3 2015$19,608,000
+137.6%
688,262
+174.7%
0.02%
+110.0%
Q2 2015$8,254,000
+47.1%
250,522
+28.4%
0.01%
+42.9%
Q1 2015$5,611,000
+25.2%
195,096
+18.5%
0.01%0.0%
Q4 2014$4,482,000
-38.2%
164,597
-51.6%
0.01%
-36.4%
Q3 2014$7,247,000
-11.6%
340,051
-6.9%
0.01%
-8.3%
Q2 2014$8,201,000
-20.2%
365,121
-10.2%
0.01%
-25.0%
Q1 2014$10,273,000
+8.1%
406,509
-1.6%
0.02%
+6.7%
Q4 2013$9,499,000
+22.4%
413,181
+1.4%
0.02%
+15.4%
Q3 2013$7,762,000
+167.7%
407,434
+102.6%
0.01%
+160.0%
Q2 2013$2,900,000201,0850.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders